Dupixent Market Expansion Driven by Rising Autoimmune Diseases

أضاف وظيفة جديدة Health

2026-07-06 12:14:04 -

The growing prevalence of chronic inflammatory diseases has accelerated demand for targeted biologic therapies that offer improved efficacy and long-term disease control. Among these therapies, Dupixent (dupilumab) has become one of the leading biologic treatments for multiple type 2 inflammatory diseases. The rapid dupilumab market growth, continued expansion of the biologics market,...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة